Comment on "Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial". Yu S, Feng J. J Thorac Oncol 2024;19:173-174.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yu S, Feng J. Comment on "Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial". J Thorac Oncol 2024;19:173-174.
PMID: 38185511